Destiny Pharma (DEST) RNS Announcements

Add to Alert list
Date Time Source Announcement
20 Aug 2024 11:52 AM
EQS
Destiny Pharma to Deliver Presentation at the...
14 Aug 2024 11:20 AM
EQS
Destiny Pharma initiates research to explore ...
13 Aug 2024 09:36 AM
EQS
Destiny Pharma plc shares now trading on JP J...
13 Aug 2024 07:00 AM
RNS
Cancellation - Destiny Pharma plc
12 Aug 2024 07:00 AM
RNS
Last Day of Dealings on AIM
05 Aug 2024 11:58 AM
RNS
Director/PDMR Shareholding
05 Aug 2024 07:00 AM
RNS
XF-73 prevents bacterial invasion of bloodstream
31 Jul 2024 11:00 AM
RNS
Result of GM and Cancellation of Trading on AIM
22 Jul 2024 07:00 AM
RNS
Treatment of XF-73 Nasal reduces antibiotic use
15 Jul 2024 07:00 AM
RNS
Proposed Cancellation of Admission to Trading
20 Jun 2024 07:00 AM
RNS
Exercise of Options and Total Voting Rights
18 Jun 2024 07:00 AM
RNS
Efficacy of XF-70 in Fungal Skin Infections
12 Jun 2024 12:16 PM
RNS
Result of Annual General Meeting
12 Jun 2024 11:00 AM
RNS
2024 Annual General Meeting and Statement
11 Jun 2024 07:00 AM
RNS
Destiny Pharma's XF-73 Nasal Awarded MHRA ILAP
24 May 2024 07:00 AM
RNS
Exercise of Options and Total Voting Rights
09 May 2024 02:35 PM
RNS
Posting of Annual Report and Notice of AGM
25 Apr 2024 07:00 AM
RNS
Full year results and review of strategic options
08 Apr 2024 07:00 AM
RNS
Notice of Full Year Results
19 Mar 2024 02:47 PM
RNS
Exercise of Options and Total Voting Rights
31 Jan 2024 07:00 AM
RNS
Clinical development update
22 Jan 2024 07:00 AM
RNS
Appointment of Nominated Adviser and Sole Broker
04 Jan 2024 07:00 AM
RNS
Year End Business Update
20 Oct 2023 07:00 AM
RNS
Grant of Share Options
19 Oct 2023 07:00 AM
RNS
Director/PDMR Shareholding
17 Oct 2023 07:01 AM
RNS
XF Pipeline Update Meeting
17 Oct 2023 07:00 AM
RNS
Publication of new microbiological data for XF-73
10 Oct 2023 07:00 AM
RNS
Director/PDMR Shareholding
04 Oct 2023 12:34 PM
RNS
Director/PDMR Shareholding
27 Sep 2023 07:00 AM
RNS
Notice of XF Pipeline Update Meeting
20 Sep 2023 07:00 AM
RNS
Interim Results
23 Aug 2023 07:00 AM
RNS
Notice of Interim Results
31 Jul 2023 12:01 PM
RNS
Publication of new data for XF-73
25 Jul 2023 07:00 AM
RNS
Appointment of new Chairman
19 Jul 2023 12:55 PM
RNS
Board changes including appointment of new CEO
07 Jul 2023 07:00 AM
RNS
Exercise of Options and Total Voting Rights
06 Jul 2023 07:00 AM
RNS
Positive findings from recent SAB meeting
29 Jun 2023 07:00 AM
RNS
Business Update
26 May 2023 03:27 PM
RNS
Director/PDMR Shareholding
26 May 2023 07:00 AM
RNS
Director Dealing
25 May 2023 12:23 PM
RNS
Result of Annual General Meeting
25 May 2023 07:00 AM
RNS
Dr Debra Barker Appointed Interim CEO
12 May 2023 12:24 PM
RNS
Grant of Share Options
02 May 2023 07:00 AM
RNS
Positive results from SPOR-COV® research
26 Apr 2023 04:10 PM
RNS
Posting of Annual Report and Notice of AGM
26 Apr 2023 10:05 AM
RNS
Exercise of Options and Total Voting Rights
13 Apr 2023 07:00 AM
RNS
Audited results for year ended 31 December 2022
04 Apr 2023 07:00 AM
RNS
Landmark data published on NTCD-M3
03 Apr 2023 07:00 AM
RNS
Notice of Results and Investor Presentation
24 Mar 2023 07:00 AM
RNS
Landmark XF-73 Phase 2 data published in journal
UK 100

Latest directors dealings